China Drug Distribution Industry Report, 2012-2015

China Drug Distribution Industry Report, 2012-2015

Category : Pharmaceuticals
Published On : September  2012
Pages : 91



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

According to China Drug Distribution Industry Report, 2012-2015 released by Sino Market Insight, the total sales of Chinese drug distribution industry is estimated to surge 102% over 2011 to RMB1.4288 trillion in 2015. 



In 2011, the sales of Chinese drug distribution industry totalized RMB942.6 billion, attaining a YoY rise of 23% if excluding non-comparable factors. In 2012, the figure will grow10% YoY to RMB1.0367 trillion. It is expected that the figure will hit RMB1.4288 trillion in 2015, and that Chinese drug retailing industry (including non-medicines) will sustain a CAGR of 11% or so in 2013-2015. 



In the forthcoming years, drug distribution in China will characterize the followings:



The industry growth will accelerate in rural market. Among the sales of seven major types of pharmaceuticals in 2011, the sales derived from rural areas climbed 27% over the same period of a year earlier (excluding non-comparable factors) to RMB146.1 billion, with the growth rate rising by roughly 4 percentage points. With the development of rural economy and residents’ concern about their own health, the pharmaceutical sale in rural areas is likely to contribute a larger proportion to the total sales. 



The concentration degree of drug retail industry will be further enhanced. Of all the sales of top 100 retail chain companies in 2011, the sales of the top 20 enterprises made up 61%, up 3 percentage points. The drug distribution industry tends to be integrated in the future.



The report covers seven chapters and 118 charts, and highlights the market size and competitive landscape of drug distribution industry in China, market status of wholesale and retail market, as well as financial performance, business development and trends of 10 major drug distribution companies.


1. Overview of Chinese Drug Distribution Industry



1.1 Definition

1.2 Industry Chain

1.3 Profit Model

1.4 International Drug Distribution Industry

1.4.1 USA

1.4.2 Japan

1.4.3 Drug Distribution Industry in China, USA, Japan and Europe

1.5 Operation Characteristics



2. Development Environment for Chinese Drug Distribution Industry



2.1 Policy Environment

2.2 China’s Macroeconomic Environment in 2011-H1 2012

2.2.1 China’s GDP

2.2.2 Per Capita Disposable Income of Urban and Rural Households

2.2.3 Engle Coefficient

2.2.4 Industrial Development

2.2.5 Import and Export

2.3 Forecast of China’s Main Macroeconomic Indicators in 2012-2013



3. Market Size and Forecast of Chinese Drug Distribution Industry



3.1 Overall Size

3.2 Sales Structure

3.3 Ownership Structure

3.4 Distribution Structure

3.5 Competitive Landscape

3.5.1 Competition Pattern of Drug Distribution Industry

3.5.2 Comparative Analysis of Top 30 Enterprises in 2011

3.6 Investment and Financing



4. Chinese Drug Distribution Industry Segments



4.1 Wholesale Industry

4.2 Retail Industry

4.2.1 Intensiveness Trend Progresses Slowly

4.2.2 Policies Bring about Opportunities and Challenges

4.2.3 Five Directions during Sub-high Growth Period



5. Chinese Drug Distribution Industry by Region



5.1 Overview

5.2 Shanghai

5.3 Beijing

5.4 Anhui Province

5.5 Zhejiang Province

5.6 Jiangsu Province

5.7 Shandong Province

5.8 Guangdong Province

5.9 Chongqing

5.10 Tianjin

5.11 Hubei Province

5.12 Other Regions



6. Operation of Pharmaceutical Logistics Companies



6.1 Shanghai Pharmaceuticals Holding Co., Ltd.

6.1.1 Profile

6.1.2 Operation

6.1.3 Business Development

6.1.4 Revenue and Profit of Main Subsidiaries

6.2 Jointown Pharmaceutical Group Co., Ltd. (600998)

6.2.1 Profile

6.2.2 Operation

6.2.3 Business Development

6.3 Nanjing Pharmaceutical Co., Ltd. 

6.3.1 Profile

6.3.2 Operation

6.3.3 Business Development

6.4 Huadong Medicine Co., Ltd. (000963)

6.4.1 Profile

6.4.2 Operation

6.4.3 Business Development

6.5 Harbin Pharmaceutical Group Co., Ltd. (600664)

6.5.1 Profile

6.5.2 Operation

6.5.3 Business Development

6.6 China Meheco Co., Ltd. (600056)

6.6.1 Profile

6.6.2 Operation

6.6.3 Business Development

6.7 Sinopharm Group Co., Ltd. (01099.HK)

6.7.1 Profile

6.7.2 Operation

6.7.3 Business Development

6.8 China Nepstar Chain Drugstore Ltd. (NYSE: NPD)

6.8.1 Profile

6.8.2 Operation

6.9 Shanghai No. 1 Pharmacy Co., Ltd. (600833)

6.9.1 Profile

6.9.2 Operation

6.9.3 Business Development

6.10 Beijing Tongrentang Co., Ltd. (600085)

6.10.1 Profile

6.10.2 Operation

6.10.3 Business Development



7. Development Trend of Drug Distribution Industry



7.1 Status Quo

7.2 Development Trend

7.2.1 Market Size will Continue to Expand

7.2.2 Adjustment of Industrial Structure Will Quicken

7.2.3 Industry Service Model and Function Will be Further Upgraded



 



List of Figures



Drug Distribution Industry Chain





Emerging Profit Model of Chinese Drug Distribution Industry



Drug Distribution Industry Chain in the U.S.



Market Concentration of Drug Distribution Industry in the U.S., 1990-2010



Drug Distribution Industry Chain in Japan



Market Concentration of Drug Distribution Industry in Japan, 1999-2010



Market Concentration of Drug Distribution Industry in China, the U.S., Japan and Europe, 2010



Policies Concerning Logistics Industry Promulgated in China, as from 2001



YoY Growth Rate of China’s GDP, 2001-2012



Per Capita Disposable Income of Urban Households in China, 1985-2011



Engel Coefficient of Urban and Rural Households in China



YoY Growth Rate of Added Value of Industrial Enterprises above Designated Size, 2000-2012



YoY Growth Rate of Export Delivery Value in China, 2008-2012



Total Import and Export Value and Growth Trend in China, 2001-2012



Import and Export Growth and Balance in China, 2001-2012



Total Import and Export Value by Country (Region), Jul. 2012



Export Volume and Value of Major Export Commodities in China, Jan.-Jul. 2012



Import Volume and Value of Major Import Commodities in China, Jan.-Jul. 2012



Export Structure of Medicines and Healthcare Products in Beijing, Jan.-Jun. 2012



Export Structure of Medicines and Healthcare Products in Shanghai, Jan.-Jun. 2012



Export Structure of Medicines and Healthcare Products in Tianjin, Jan.-Jun. 2012



Forecast of Main Macroeconomic Indicators in China, 2012-2013E



Total Sales of Pharmaceuticals, 2007-2015E



Main Economic Indicators of Drug Distribution Enterprises, 2011



Accounts Receivable of Drug Wholesale Enterprises, 2011



Operating Revenue Structure of Drug Distribution Enterprises  (above Designated Size) by Ownership, 2011



Total Profit Structure of Drug Distribution Enterprises (above Designated Size) by Ownership, 2011



Merchandise Distribution Struture of Pharmaceutical Wholesale Enterprises, 2011



Logistics Cost Structure of Drug Wholesale Enterprises, 2011



Market Share of Drug Distribution and Major Distribution Enterprises in Major Regions in China, 2011



Market Structure of Three Formats of Chinese Drug Distribution Industry, 2012



Competitive Landscape of Drug Distribution Market in Beijing, 2011-2015E



Competitive Landscape of Drug Distribution Market in Shanghai, 2011-2015E



Competitive Landscape of Drug Distribution Market in Guangdong, 2011-2015E



Distribution Structure of Key Drug Wholesale Enterprises by Sales Channel, 2012



Top 30 Wholesale Enterprises by Operating Revenue, 2011



Top 30 Retail Enterprises by Total Sales, 2011



PE / VC of Health Care Product Distributors Industry in China, 2011-2012



PE / VC of Health Care Product Distributors Industry in China, 2012



Market Size of Drug Wholesale Industry in China, 2010-2015E



Revenue of Drug Wholesale Enterprises in China by Type, 2011-2015E



Market Size of Drug Retail Industry in China, 2010-2015E



Market Size of Drug Retail Industry in China by Type, 2010-2015E



Drug Sales in China by Type, 2007-2015E



Drug Sales in Shanghai by Type, 2010-2015E



Drug Sales in Beijing by Type, 2010-2015E



Drug Sales in Anhui by Type, 2010-2015E



Drug Sales in Zhejiang by Type, 2010-2015E



Drug Sales in Jiangsu by Type, 2010-2015E



Drug Sales in Shandong by Type, 2010-2015E



Drug Sales in Guangdong by Type, 2010-2015E



Drug Sales in Chongqing by Type, 2010-2015E



Drug Sales in Tianjin by Type, 2010-2015E



Drug Sales in Hubei by Type, 2010-2015E



Total Drug Sales in China by Region, 2011-2015E



Drug Sales in China by Region, 2010-2015E



Sales of Chinese Patent Drug in China by Region, 2010-2015E



Sales of Traditional Chinese Medicine in China by Region, 2011-2015E



Sales of Medical Equipment in China by Region, 2010-2015E



Key Indicators of Shanghai Pharmaceuticals Holding Co., Ltd, 2011-2012



Income Statement Abstract of Shanghai Pharmaceuticals Holding Co., Ltd, 2011-2012



Balance Sheet Abstract of Shanghai Pharmaceuticals Holding Co., Ltd, 2011-2012



Cash Flow Statement Abstract of Shanghai Pharmaceuticals Holding Co., Ltd, 2011-2012



Revenue and Gross Margin of  Shanghai Pharmaceuticals Holding Co., Ltd by Product, 2010-2012



Revenue and Gross Margin of Shanghai Pharmaceuticals Holding Co., Ltd by Region, 2010-2012



Revenue and Profit of Major Subsidiaries of Shanghai Pharmaceuticals Holding Co., Ltd.



Key Indicators of Jointown Pharmaceutical Group Co., Ltd., 2011-2012



Income Statement Abstract of Jointown Pharmaceutical Group Co., Ltd., 2011-2012



Balance Sheet Abstract of Jointown Pharmaceutical Group Co., Ltd., 2011-2012



Cash Flow Statement Abstract of Jointown Pharmaceutical Group Co., Ltd., 2011-2012



Revenue and Gross Margin of Jointown Pharmaceutical Group Co., Ltd. by Product, 2010-2012



Revenue of Jointown Pharmaceutical Group Co., Ltd. by Region, 2010-2012



Key Indicators of Nanjing Pharmaceutical Company Limited, 2011-2012



Income Statement Abstract of Nanjing Pharmaceutical Company Limited, 2011-2012



Balance Sheet Abstract of Nanjing Pharmaceutical Company Limited, 2011-2012



Cash Flow Statement Abstract of Nanjing Pharmaceutical Company Limited, 2011-2012



Revenue and Gross Margin of Nanjing Pharmaceutical Company Limited by Product, 2010-2012



Revenue of Nanjing Pharmaceutical Company Limited by Region, 2010-2012



Key Indicators of Huadong Medicine Co., Ltd., 2011-2012



Income Statement Abstract of Huadong Medicine Co., Ltd., 2011-2012



Balance Sheet Abstract of Huadong Medicine Co., Ltd., 2011-2012



Cash Flow Statement Abstract of Huadong Medicine Co., Ltd., 2011-2012



Revenue and Gross Margin of Huadong Medicine Co., Ltd. by Product, 2010-2012



Revenue and Gross Margin of Huadong Medicine Co., Ltd. by Region, 2010-2012



Key Indicators of Harbin Pharmaceutical Group Co., Ltd., 2011-2012



Income Statement Abstract of Harbin Pharmaceutical Group Co., Ltd., 2011-2012



Balance Sheet Abstract of Harbin Pharmaceutical Group Co., Ltd., 2011-2012



Cash Flow Statement Abstract of Harbin Pharmaceutical Group Co., Ltd., 2011-2012



Revenue and Gross Margin of Harbin Pharmaceutical Group Co., Ltd. by Product, 2011-2012



Revenue and Gross Margin of Harbin Pharmaceutical Group Co., Ltd. by Region, 2011-2012



Key Indicators of China Meheco Co., Ltd., 2011-2012



Income Statement Abstract of China Meheco Co., Ltd., 2011-2012



Balance Sheet Abstract of China Meheco Co., Ltd., 2011-2012



Cash Flow Statement Abstract of China Meheco Co., Ltd., 2011-2012



Revenue and Gross Margin of China Meheco Co., Ltd. by Product, 2011-2012



Key Indicators of Sinopharm Group Co., Ltd., 2011-2012



Balance Sheet Abstract of Sinopharm Group Co., Ltd., 2011-2012



Income Data of China Nepstar,2007-2011



Consolidated Balance Sheet Data of China Nepstar,2007-2011



Key Indicators of Shanghai No.1 Pharmacy Co., Ltd., 2011-2012



Income Statement Abstract of Shanghai No.1 Pharmacy Co., Ltd., 2011-2012



Balance Sheet Abstract of Shanghai No.1 Pharmacy Co., Ltd., 2011-2012



Cash Flow Statement Abstract of Shanghai No.1 Pharmacy Co., Ltd., 2011-2012



Revenue and Gross Margin of Shanghai No.1 Pharmacy Co., Ltd. by Product, 2011-2012



Revenue and Gross Margin of Shanghai No.1 Pharmacy Co., Ltd. by Region, 2011-2012



Key Indicators of Beijing Tongrentang Co., Ltd, 2011-2012



Income Statement Abstract of Beijing Tongrentang Co., Ltd, 2011-2012



Balance Sheet Abstract of Beijing Tongrentang Co., Ltd, 2011-2012



Cash Flow Statement Abstract of Beijing Tongrentang Co., Ltd, 2011-2012



Revenue and Gross Margin of Beijing Tongrentang Co., Ltd by Region, 2011-2012


Enquiry Before Buy
image
Can´t read the image ? refresh here.